120
Participants
Start Date
October 31, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
cAd3-EBOZ vaccine
Placebo (for cAd3-EBOZ vaccine)
Diluent
Clinical Trial Unit Lausanne, Lausanne
Collaborators (1)
Infectious Disease Service, CHUV, Lausanne
UNKNOWN
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
OTHER
University of Lausanne Hospitals
OTHER
Swiss Tropical & Public Health Institute
OTHER
University of Lausanne
OTHER
GlaxoSmithKline
INDUSTRY
World Health Organization
OTHER
Immunology and Allergy Service, CHUV, Lausanne
UNKNOWN
Centre Hospitalier Universitaire Vaudois
OTHER